European Commission warned not to "rush" update to counterfeit drugs directive
The amendments to the EU directive covering counterfeit medicines must not be rushed through, the former member of the European Parliament who made the proposals has told WTR.
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.